MaxCyte (MXCT) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for MaxCyte (MXCT).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||
Total Revenue | 4.50M (-6.05%) | 4.79M (+4.13%) | 4.60M (-20.96%) | 5.82M (+1.39%) | 5.74M (-5.12%) | 6.05M (+7.84%) | 5.61M (+12.88%) | 4.97M (-10.93%) | 5.58M (+17.23%) | 4.76M (+14.42%) | 4.16M (-25.98%) | 5.62M (+13.31%) | 4.96M (-36.08%) | 7.76M (+8.53%) | 7.15M (+2.44%) | 6.98M (+1.75%) | 6.86M (-8.66%) | 7.51M (+33.87%) | 5.61M (+32.94%) | 4.22M (-0.47%) | 4.24M (-49.88%) | 8.46M (+81.16%) | 4.67M (+100.43%) | 2.33M | - |
Cost Of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.73M | 940K (+20.51%) | 780K | - | -1.20M | 730K (+55.32%) | 470K | - |
Costof Goods And Services Sold | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.73M | 940K (+20.51%) | 780K | - | -1.20M | 730K (+55.32%) | 470K | - |
Gross Profit | 8.08M (+42.00%) | 5.69M (+8.80%) | 5.23M (-25.18%) | 6.99M (-21.37%) | 8.89M (+38.69%) | 6.41M (+2.72%) | 6.24M (-30.20%) | 8.94M (-10.06%) | 9.94M (-29.45%) | 14M (+95.42%) | 7.21M (-6.00%) | 7.67M (+1.19%) | 7.58M (-30.33%) | 11M (+17.37%) | 9.27M (+9.19%) | 8.49M (-19.30%) | 11M (+17.81%) | 8.93M (-2.93%) | 9.20M (+45.57%) | 6.32M (+8.97%) | 5.80M (-54.29%) | 13M (+110.45%) | 6.03M (+28.85%) | 4.68M | - |
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 3.86M (+15.57%) | 3.34M (-37.22%) | 5.32M (-15.15%) | 6.27M (+6.27%) | 5.90M (+27.98%) | 4.61M (-13.35%) | 5.32M (-5.34%) | 5.62M (-15.87%) | 6.68M (+14.38%) | 5.84M (-6.71%) | 6.26M (+10.60%) | 5.66M (-6.45%) | 6.05M (+5.58%) | 5.73M (+7.50%) | 5.33M (+13.40%) | 4.70M (+24.67%) | 3.77M (+11.54%) | 3.38M (+22.91%) | 2.75M (-14.06%) | 3.20M (-47.37%) | 6.08M (-33.41%) | 9.13M (+101.99%) | 4.52M (+10.51%) | 4.09M | - |
Selling General And Administrative | 5.97M (+8.94%) | 5.48M (-9.12%) | 6.03M (-25.37%) | 8.08M (-5.28%) | 8.53M (+18.31%) | 7.21M (-6.97%) | 7.75M (+1.44%) | 7.64M (+7.61%) | 7.10M (-12.24%) | 8.09M (+18.62%) | 6.82M (-10.97%) | 7.66M (+2.13%) | 7.50M (+32.74%) | 5.65M (-12.27%) | 6.44M (-9.30%) | 7.10M (+7.09%) | 6.63M (+9.95%) | 6.03M (+12.71%) | 5.35M (+24.42%) | 4.30M (+43.33%) | 3.00M (-13.29%) | 3.46M (+49.78%) | 2.31M (+45.28%) | 1.59M | - |
Operating Expenses | 14M (-15.66%) | 17M (-12.69%) | 19M (-8.67%) | 21M (+0.14%) | 21M (+9.74%) | 19M (-4.83%) | 20M (-2.97%) | 21M (-5.85%) | 22M (+0.09%) | 22M (+4.87%) | 21M (+2.03%) | 21M (-0.05%) | 21M (+17.70%) | 18M (+3.77%) | 17M (-1.39%) | 17M (+17.37%) | 15M (+5.76%) | 14M (+19.24%) | 12M (+8.38%) | 11M (-11.75%) | 12M (-32.61%) | 18M (+103.61%) | 8.87M (+17.80%) | 7.53M | - |
Depreciation And Amortization | 1.05M (-6.25%) | 1.12M (+7.69%) | 1.04M (-3.70%) | 1.08M (-1.82%) | 1.10M (+3.77%) | 1.06M (-0.93%) | 1.07M (-0.93%) | 1.08M (-2.70%) | 1.11M (+0.91%) | 1.10M (+1.85%) | 1.08M (+4.85%) | 1.03M (+7.29%) | 960K (+4.35%) | 920K (+24.32%) | 740K (+34.55%) | 550K (+12.24%) | 490K (+16.67%) | 420K (+13.51%) | 370K (+12.12%) | 330K (+3.13%) | 320K (-36.00%) | 500K (+72.41%) | 290K (+11.54%) | 260K | - |
Operating Income | |||||||||||||||||||||||||
Operating Income | -6.18M (-44.97%) | -11.23M (-20.64%) | -14.15M (-0.56%) | -14.23M (+15.79%) | -12.29M (-4.73%) | -12.90M (-8.19%) | -14.05M (+17.38%) | -11.97M (-2.44%) | -12.27M (+51.48%) | -8.10M (-41.94%) | -13.95M (+6.73%) | -13.07M (-0.83%) | -13.18M (+95.26%) | -6.75M (-12.45%) | -7.71M (-11.78%) | -8.74M (+110.10%) | -4.16M (-16.13%) | -4.96M (+103.28%) | -2.44M (-44.80%) | -4.42M (-30.61%) | -6.37M (+18.62%) | -5.37M (+89.08%) | -2.84M (0.00%) | -2.84M | - |
Ebit | -6.18M (-44.97%) | -11.23M (-20.64%) | -14.15M (-0.56%) | -14.23M (+15.79%) | -12.29M (-4.73%) | -12.90M (-8.19%) | -14.05M (+17.38%) | -11.97M (-2.44%) | -12.27M (+51.48%) | -8.10M (-41.94%) | -13.95M (+6.73%) | -13.07M (-0.83%) | -13.18M (+95.26%) | -6.75M (-12.45%) | -7.71M (-11.78%) | -8.74M (+110.10%) | -4.16M (-16.13%) | -4.96M (+103.28%) | -2.44M (-44.80%) | -4.42M (-30.61%) | -6.37M (+175.76%) | -2.31M (-18.66%) | -2.84M (0.00%) | -2.84M (-7.19%) | -3.06M |
EBITDA | -5.14M (-49.16%) | -10.11M (-22.82%) | -13.10M (-0.38%) | -13.15M (+17.41%) | -11.20M (-5.41%) | -11.84M (-8.85%) | -12.99M (+19.28%) | -10.89M (-2.42%) | -11.16M (+59.66%) | -6.99M (-45.69%) | -12.87M (+6.80%) | -12.05M (-1.39%) | -12.22M (+109.61%) | -5.83M (-16.36%) | -6.97M (-14.90%) | -8.19M (+123.16%) | -3.67M (-19.16%) | -4.54M (+118.27%) | -2.08M (-49.14%) | -4.09M (-32.51%) | -6.06M (+234.81%) | -1.81M (-29.02%) | -2.55M (-1.54%) | -2.59M (-15.36%) | -3.06M |
Other Income / Expenses | |||||||||||||||||||||||||
Interest Income | 1.44M (-11.66%) | 1.63M (-5.78%) | 1.73M (-7.49%) | 1.87M (-7.88%) | 2.03M (-11.74%) | 2.30M (-8.00%) | 2.50M (-3.47%) | 2.59M (-5.82%) | 2.75M (-2.48%) | 2.82M (+4.44%) | 2.70M (+5.47%) | 2.56M (+11.30%) | 2.30M (+17.95%) | 1.95M (+40.29%) | 1.39M (+189.58%) | 480K (+433.33%) | 90K (+12.50%) | 80K (+60.00%) | 50K (+400.00%) | 10K (0.00%) | 10K (-80.00%) | 50K (+400.00%) | 10K (0.00%) | 10K | - |
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10K (-50.00%) | 20K | - | - | - |
Net Interest Income | 1.44M (-11.66%) | 1.63M (-5.78%) | 1.73M (-7.49%) | 1.87M (-7.88%) | 2.03M (-11.74%) | 2.30M (-8.00%) | 2.50M (-3.47%) | 2.59M (-5.82%) | 2.75M (-2.48%) | 2.82M (+4.44%) | 2.70M (+5.47%) | 2.56M (+11.30%) | 2.30M (+17.95%) | 1.95M (+40.29%) | 1.39M (+189.58%) | 480K (+433.33%) | 90K (+12.50%) | 80K (+60.00%) | 50K (+400.00%) | 10K | - | 30K (+200.00%) | 10K (0.00%) | 10K | - |
Other Non Operating Income | 1.44M (-80.19%) | 7.27M (+320.23%) | 1.73M (-7.49%) | 1.87M (-7.88%) | 2.03M (-79.98%) | 10M (+305.60%) | 2.50M (-3.47%) | 2.59M (-5.82%) | 2.75M (-73.51%) | 10M (+284.44%) | 2.70M (+5.47%) | 2.56M (+11.30%) | 2.30M (-39.31%) | 3.79M (+196.09%) | 1.28M (+166.67%) | 480K (+433.33%) | 90K | -890.00K (+270.83%) | -240.00K | - | -730.00K (-3.95%) | -760.00K (+192.31%) | -260.00K (+62.50%) | -160.00K | - |
Net Income | |||||||||||||||||||||||||
Income Before Tax | -4.75M (-50.52%) | -9.60M (-22.71%) | -12.42M (+0.49%) | -12.36M (+20.47%) | -10.26M (-3.21%) | -10.60M (-8.30%) | -11.56M (+23.37%) | -9.37M (-1.68%) | -9.53M (+80.49%) | -5.28M (-53.07%) | -11.25M (+7.04%) | -10.51M (-3.40%) | -10.88M | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -4.75M (-50.52%) | -9.60M (-22.71%) | -12.42M (+0.49%) | -12.36M (+20.47%) | -10.26M (-3.21%) | -10.60M (-8.30%) | -11.56M (+23.37%) | -9.37M (-1.68%) | -9.53M (+80.49%) | -5.28M (-53.07%) | -11.25M (+7.04%) | -10.51M (-3.40%) | -10.88M (+126.20%) | -4.81M (-25.19%) | -6.43M (-22.15%) | -8.26M (+102.95%) | -4.07M (-16.43%) | -4.87M (+81.72%) | -2.68M (-39.37%) | -4.42M (-37.83%) | -7.11M (+168.30%) | -2.65M (-14.52%) | -3.10M (+3.33%) | -3.00M (-1.96%) | -3.06M |
Net Income | -4.75M (-50.52%) | -9.60M (-22.71%) | -12.42M (+0.49%) | -12.36M (+20.47%) | -10.26M (-3.21%) | -10.60M (-8.30%) | -11.56M (+23.37%) | -9.37M (-1.68%) | -9.53M (+80.49%) | -5.28M (-53.07%) | -11.25M (+7.04%) | -10.51M (-3.40%) | -10.88M (+126.20%) | -4.81M (-25.19%) | -6.43M (-22.15%) | -8.26M (+102.95%) | -4.07M (-16.43%) | -4.87M (+81.72%) | -2.68M (-39.37%) | -4.42M (-37.83%) | -7.11M (+168.30%) | -2.65M (-14.52%) | -3.10M (+3.33%) | -3.00M (-1.96%) | -3.06M |